ATRC's cryoSPHERE MAX probe cuts freeze times by 50%, advancing Cryo Nerve Block therapy to improve post-op pain relief and reduce opioid dependency risks.
AtriCure (Nasdaq: ATRC) announced today that it has launched the new CryoSphere Max cryoablation probe technology.
AtriCure, Inc. ( NASDAQ:ATRC ) shareholders should be happy to see the share price up 17% in the last quarter. But ...
AQR Capital Management LLC boosted its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 38.2% in the second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback